Table 3:
Open in new tab

MACCE and all-cause mortality after IPTW.

OutcomesHR (95% CI)P-value
MACCE
 Developed insomnia vs no insomnia1.26 (1.25–1.28)<.001
 Improved insomnia vs no insomnia1.31 (1.29–1.33)<.001
 Persistent insomnia vs no insomnia1.39 (1.37–1.41)<.001
All-cause mortality
 Developed insomnia vs no insomnia1.31 (1.29–1.33)<.001
 Improved insomnia vs no insomnia1.41 (1.40–1.43)<.001
 Persistent insomnia vs no insomnia1.47 (1.44–1.49)<.001
OutcomesHR (95% CI)P-value
MACCE
 Developed insomnia vs no insomnia1.26 (1.25–1.28)<.001
 Improved insomnia vs no insomnia1.31 (1.29–1.33)<.001
 Persistent insomnia vs no insomnia1.39 (1.37–1.41)<.001
All-cause mortality
 Developed insomnia vs no insomnia1.31 (1.29–1.33)<.001
 Improved insomnia vs no insomnia1.41 (1.40–1.43)<.001
 Persistent insomnia vs no insomnia1.47 (1.44–1.49)<.001
Table 3:
Open in new tab

MACCE and all-cause mortality after IPTW.

OutcomesHR (95% CI)P-value
MACCE
 Developed insomnia vs no insomnia1.26 (1.25–1.28)<.001
 Improved insomnia vs no insomnia1.31 (1.29–1.33)<.001
 Persistent insomnia vs no insomnia1.39 (1.37–1.41)<.001
All-cause mortality
 Developed insomnia vs no insomnia1.31 (1.29–1.33)<.001
 Improved insomnia vs no insomnia1.41 (1.40–1.43)<.001
 Persistent insomnia vs no insomnia1.47 (1.44–1.49)<.001
OutcomesHR (95% CI)P-value
MACCE
 Developed insomnia vs no insomnia1.26 (1.25–1.28)<.001
 Improved insomnia vs no insomnia1.31 (1.29–1.33)<.001
 Persistent insomnia vs no insomnia1.39 (1.37–1.41)<.001
All-cause mortality
 Developed insomnia vs no insomnia1.31 (1.29–1.33)<.001
 Improved insomnia vs no insomnia1.41 (1.40–1.43)<.001
 Persistent insomnia vs no insomnia1.47 (1.44–1.49)<.001
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close